Abbott Laboratories (ETR:ABL)

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $11.14B USD in the quarter ending June 30, 2025, with 7.37% growth. This brings the company's revenue in the last twelve months to $43.11B, up 5.85% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.

• Revenue (ttm): $43.11B
• Revenue Growth: +5.85%
• P/S Ratio: 5.41
• Revenue / Employee: $378.15K
• Employees: 114,000
• Market Cap: 198.50B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.95B	1.84B	4.59%
Dec 31, 2023	40.11B	-3.54B	-8.12%
Dec 31, 2022	43.65B	578.00M	1.34%
Dec 31, 2021	43.08B	8.47B	24.47%
Dec 31, 2020	34.61B	2.70B	8.48%
Dec 31, 2019	31.90B	1.33B	4.34%
Dec 31, 2018	30.58B	3.19B	11.64%
Dec 31, 2017	27.39B	6.54B	31.35%
Dec 31, 2016	20.85B	448.00M	2.20%
Dec 31, 2015	20.41B	158.00M	0.78%
Dec 31, 2014	20.25B	590.00M	3.00%
Dec 31, 2013	19.66B	607.00M	3.19%
Dec 31, 2012	19.05B	-2.36B	-11.01%
Dec 31, 2011	21.41B	-13.76B	-39.13%
Dec 31, 2010	35.17B	4.40B	14.31%
Dec 31, 2009	30.76B	1.24B	4.19%
Dec 31, 2008	29.53B	3.61B	13.94%
Dec 31, 2007	25.91B	3.44B	15.30%
Dec 31, 2006	22.48B	138.51M	0.62%
Dec 31, 2005	22.34B	-	-